October 09, 2026

FDA approves atezolizumab for dMMR colon cancer

In the phase 3 ATOMIC trial, adjuvant atezolizumab plus chemotherapy halved the risk of recurrence or death in stage 3 patients.

MDSpire News

October 09, 2026

FDA approves olanzapine injection for schizophrenia

All 3 monthly doses improved schizophrenia symptoms versus placebo in the phase 3 SOLARIS trial.

MDSpire News

October 09, 2026

APT may fall short in pulsatile tinnitus

Low sensitivity and specificity suggest a negative tracing should not deter further imaging evaluation.

MDSpire News

October 09, 2026

FDA approves pritelivir for refractory HSV lesions

In a phase 3 trial, complete lesion healing occurred in 63% of patients receiving pritelivir vs. 34% receiving comparator treatments.

MDSpire News

October 09, 2026

Medical debt linked to higher late-stage cancer rates

Lung cancer showed the strongest absolute association, while prostate and breast cancer findings diverged from the broader pattern.

MDSpire News

October 09, 2026

CDC flags neuro symptoms after unapproved botulinum toxin

None of the 3 symptomatic patients knew the injected product lacked FDA approval.

MDSpire News

October 09, 2026

CDC recommends 2026–2027 COVID vaccines for all adults

Updated guidance recommends vaccination for adults aged 18 years and older, with pediatric recommendations based on immune status.

MDSpire News

October 08, 2026

Asymptomatic carriage may fuel C difficile spread

Modeling in oncology units attributed 92% of transmission-related colonization to patients without symptomatic infection.

MDSpire News

October 08, 2026

FDA flags potential cardiac risk with evenamide

Four deaths among evenamide-treated patients prompted FDA concerns about possible fatal arrhythmias, although a causal link remains unconfirmed.

MDSpire News

October 08, 2026

Medical Oddities: Kratom tea takes a cardiac turn

Tea with a troubling cardiac turn, frozen fish cake, rebuilding cartilage, and a bedtime snack this week.

MDSpire News